Meyka AI API is live for developers.Start building.
Advertisement
Procaps Group, S.A.

Procaps Group, S.A. (PROCW) Stock Overview

Explore Procaps Group, S.A.’s financial performance, market position, analyst ratings, and future outlook.

PROCW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.02
$0.005(33.79%)
U.S. Market is Open · 14:57
Advertisement

Procaps Group, S.A. (PROCW)

Meyka AI Score

Z

Key Financials

Market Cap2M
P/E Ratio2.40
EPS (TTM)N/A
ROE-2.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PROCW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Procaps Group, S.A. (PROCW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2.40 and a market capitalization of 2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-92.21%
5-Year Change
-98.20%
All-Time (Max) Change
-98.20%

Contact Information

http://www.procapsgroup.com
356 7995 6138
9 rue de Bitbourg, Luxembourg City, NaN, 1273

Company Facts

55,000 Employees
IPO DateSep 30, 2021
CountryLU

Frequently Asked Questions